Rochester: 12:15 pm, Gonda 8-104/Joseph 1-242
Florida: 1:15 pm, MA-3-051S

Visiting Faculty
Kevin Klos, M.D.
The Movement Disorder Clinic of Oklahoma
"Duopa Therapy for Advanced Parkinson's Disease"

Learning objectives:
Summarize patient selection for Duopa therapy
Summarize clinical outcomes and adverse effects of Duopa therapy
Describe complications of PEGJ placement for Duopa therapy
Identify alternative treatment options for advanced Parkinson's disease patients

The presenter (and/or spouse/partner) has the following relevant financial relationships to diclose:
Consultant - Abbvie, Impax, UCB; Speaker's Bureau - Abbvie, UCB; Grant/Research Support - Impax, UCB, Neuroderm; Honoraria - Abbvie, UCB
The presenter intends to discuss off-label/investigative uses of the following commercial products/devices:
Manufacturer/Provider - Abbvie; Product/Device - Duopa therapy